Skip to content
LexBuild

National Human Genome Research Institute; Notice of CLosed Meeting

---
identifier: "/us/fr/02-3445"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Human Genome Research Institute; Notice of CLosed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "02-3445"
section_name: "National Human Genome Research Institute; Notice of CLosed Meeting"
positive_law: false
currency: "2002-02-13"
last_updated: "2002-02-13"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-3445"
document_type: "notice"
publication_date: "2002-02-13"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "67 FR 6722"
fr_volume: 67
---

#  National Human Genome Research Institute; Notice of CLosed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of hte following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in other. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Human Genome Research Institute Special Emphasis Panel.

*Date:* March 5, 2002.

*Time:* 2 p.m. to 4 p.m.

*Agenda:* To review and evaluate granta applications.

*Place:* NHGRI Conference Rm B2B32, 31 Center Dr., Bethesda, MD 20892, (Telephone Conference Call).

*Contact Person:* Rudy O. Pozzatti, PHD, Scientific Review Administrator, Office of Scientific Review, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, 301-402-0838.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

Dated: February 6, 2002.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.